Kitazato Corporation (TYO:368A)

Market Cap	64.12B
Revenue (ttm)	10.71B
Net Income (ttm)	3.89B
Shares Out	40.00M
EPS (ttm)	97.23
PE Ratio	16.49
Forward PE	17.38
Dividend	41.00 (2.59%)
Ex-Dividend Date	n/a

Volume	110,900
Average Volume	183,490
Open	1,604.00
Previous Close	1,584.00
Day's Range	1,587.00 - 1,614.00
52-Week Range	1,305.00 - 2,158.00
Beta	n/a
RSI	56.37
Earnings Date	Feb 6, 2026

About Kitazato

Kitazato Corporation researches, develops, manufactures, and markets medical devices and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company was formerly known as Kitazato Biopharma Co., Ltd. The company was founded in 1998 and is based in Shizuoka, Japan. Kitazato Corporation is a subsidiary of Kitasato Shoji Co., Ltd.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 86
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 368A

Financial Performance

In 2024, Kitazato's revenue was 10.30 billion, an increase of 2.20% compared to the previous year's 10.08 billion. Earnings were 3.79 billion, a decrease of -4.63%.